Celon Pharma S.A. (FRA:8RP)

Market Cap	275.05M
Revenue (ttm)	53.85M
Net Income (ttm)	-28.68M
Shares Out	n/a
EPS (ttm)	-0.55
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	4.810
Previous Close	4.865
Day's Range	4.810 - 4.810
52-Week Range	4.440 - 6.650
Beta	n/a
RSI	49.21
Earnings Date	Nov 19, 2025

About Celon Pharma

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

• Industry: Pharmaceutical Preparations
• Founded: 2002
• Employees: 558
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 8RP

Financial Performance

In 2024, Celon Pharma's revenue was 205.55 million, a decrease of -4.25% compared to the previous year's 214.66 million. Losses were -34.45 million, 22.5% more than in 2023.

Financial numbers in PLN